EUVIMEDEUVIMED entdecken
Open Access

BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia

Laura López-Hernández iD, Stephanie J Crowley iD, Sara Cea-Sánchez iD, Ricardo de Arellano iD, Neetij Krishnan iD, Patrick Toolan-Kerr iD, Lynn White, Domenico Ignoti, Emily Soto-Hidalgo iD, Stefano Gustincich iD, Román González-Prieto iD, Luca Pandolfini iD und 7 weitere

Science Advances · 06.11.2026 · 12 (45)

DOI: 10.1126/sciadv.aeg0571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Laura López-Hernández und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, 41092 Seville, Spain. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Activating Transcription Factor 4, RNA Splicing, Repressor Proteins. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is driven by genetic alterations and non-mutational mechanisms that disrupt normal hematopoiesis and support leukemic cell survival. While the mutational landscape of AML is well characterized, the non-genetic processes sustaining leukemic maintenance remain less understood. Using human AML cells and murine models, we identify BCL2-associated transcription factor 1 (BCLAF1) as a key regulator of leukemic progression through control of mRNA processing. BCLAF1 physically associates with core spliceosome components and regulates alternative splicing programs in leukemic cells. Mechanistically, BCLAF1 is required for productive splicing of activating transcription factor 4 (ATF4) mRNA, thereby sustaining ATF4 protein levels and downstream metabolic gene expression programs. Loss of BCLAF1 reduces ATF4 levels, leading to impaired de novo amino acid biosynthesis and increased sensitivity to venetoclax. Together, these findings uncover a previously unrecognized mechanism linking RNA splicing control to metabolic adaptation in AML, identifying BCLAF1 as a potential therapeutic vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteActivating Transcription Factor 4RNA SplicingRepressor ProteinsHumansAnimalsMiceSpliceosomesCell Line, TumorMetabolic ReprogrammingAlternative SplicingRNA, MessengerGene Expression Regulation, LeukemicTumor Suppressor Proteins

Substanzen

Activating Transcription Factor 4BCLAF1 protein, humanRepressor ProteinsATF4 protein, humanRNA, MessengerTumor Suppressor Proteins

Autor:innen und Institutionen

  • Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, 41092 Seville, Spain.
  • Departamento de Genética, Universidad de Sevilla, 41012 Seville, Spain.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
  • Department of Molecular Biotechnology and Health sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy.
  • Center for Human Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy.
  • Departamento de Biología Celular, Universidad de Sevilla, 41012 Seville, Spain.

ORCID-Profile: Laura López-Hernández, Stephanie J Crowley, Sara Cea-Sánchez, Ricardo de Arellano, Neetij Krishnan, Patrick Toolan-Kerr, Emily Soto-Hidalgo, Stefano Gustincich, Román González-Prieto, Luca Pandolfini, Patricia Altea-Manzano, Jeffrey A Magee, Francesca Ferraro, Samuel J Taylor, Jeffrey J Bednarski, Gonzalo Millán-Zambrano

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health
  • Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona
  • Agencia Estatal de Investigación
  • Junta de Andalucía
  • European Research Council

Zitieren

APA

López-Hernández, L., Crowley, S. J., Cea-Sánchez, S., de Arellano, R., Krishnan, N., Toolan-Kerr, P., White, L., Ignoti, D., Soto-Hidalgo, E., Gustincich, S., González-Prieto, R., Pandolfini, L., Barbieri, I., Altea-Manzano, P., Magee, J. A., Ferraro, F., Taylor, S. J., Bednarski, J. J., & Millán-Zambrano, G. (2026). BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aeg0571

Vancouver

López-Hernández L, Crowley SJ, Cea-Sánchez S, de Arellano R, Krishnan N, Toolan-Kerr P, et al. BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia. Science Advances. 2026;12(45). doi:10.1126/sciadv.aeg0571

BibTeX
@article{LpezHernndez2026,
  author = {López-Hernández, Laura and Crowley, Stephanie J and Cea-Sánchez, Sara and de Arellano, Ricardo and Krishnan, Neetij and Toolan-Kerr, Patrick and White, Lynn and Ignoti, Domenico and Soto-Hidalgo, Emily and Gustincich, Stefano and González-Prieto, Román and Pandolfini, Luca and Barbieri, Isaia and Altea-Manzano, Patricia and Magee, Jeffrey A and Ferraro, Francesca and Taylor, Samuel J and Bednarski, Jeffrey J and Millán-Zambrano, Gonzalo},
  title = {BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {45},
  doi = {10.1126/sciadv.aeg0571}
}
Kostenlos starten →